Literature DB >> 1352496

Comparison of casual, ambulatory and self-measured blood pressure in a study of nitrendipine vs bisoprolol.

T Mengden1, B Bättig, M Schubert, T Jeck, B Weisser, C Buddeberg, W Vetter.   

Abstract

In a double-blind, placebo-controlled study the antihypertensive efficacy and tolerability of a single morning dose of either 10 mg bisoprolol (n = 26) or 20 mg nitrendipine (n = 27) were investigated. Blood pressure was measured by three techniques: (1) Casual blood pressure 24 h after the dose; (2) ambulatory 24-h whole-day monitoring; and (3) self-recorded blood pressure in the morning 24 h after the dose (6-8 a.m.) and in the evening (6-8 p.m.). After 4 weeks of therapy bisoprolol had produced a highly significant reduction in blood pressure as assessed by causal, ambulatory day- and night-time monitoring, and self-measured morning and evening readings. Bisoprolol was significantly more effective than nitrendipine, which did not induce a significant reduction in the ambulatory night-time recordings. Whole-day ambulatory blood pressure profiles showed an antihypertensive effect of bisoprolol throughout the entire 24-h period. 24-h blood pressure curves after nitrendipine demonstrated a markedly shorter duration of action, with no reduction in early morning blood pressure. Adverse effects and tolerability of the two drugs were comparable. The average changes in systolic and diastolic blood pressure after bisoprolol and nitrendipine in 2-h periods of ambulatory monitoring (6-8 a.m. and 6-8 p.m.) and self-measured blood pressure (6-8 a.m. and 6-8 p.m.) showed a good agreement between ambulatory and self-measured blood pressure determinations with no significant difference between the methods. The results show that 24 h antihypertensive efficacy was more pronounced for bisoprolol than for nitrendipine at the doses studied.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352496     DOI: 10.1007/bf00265917

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  46 in total

1.  Effect of fish oil on blood pressure and serum lipids in hypertension and hyperlipidaemia.

Authors:  A Steiner; R Oertel; B Bättig; W Pletscher; B Weiss; P Greminger; W Vetter
Journal:  J Hypertens Suppl       Date:  1989-05

2.  Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.

Authors:  S S Steiner; A J Friedhoff; B L Wilson; J R Wecker; J P Santo
Journal:  J Hum Hypertens       Date:  1990-06       Impact factor: 3.012

3.  [Nitrendipine, a new calcium antagonist, as basis therapy in essential hypertension].

Authors:  H Groth; M Stimpel; D Edmonds; R Mosca; W Vetter
Journal:  Schweiz Rundsch Med Prax       Date:  1985-05-07

4.  Use of home-blood-pressure measurement to compare the efficacy of two diuretics. Effects of methylclothiazide and frusemide on blood pressure and plasma renin activity and electrolytes.

Authors:  R D Gordon; C G Pawsey; M W O'Halloran; M L Abbott; L L Wilson; H Silverstone
Journal:  Med J Aust       Date:  1971-09-11       Impact factor: 7.738

5.  Usefulness of home BP determination in treating borderline hypertension.

Authors:  C Cottier; S Julius; S V Gajendragadkar; M A Schork
Journal:  JAMA       Date:  1982-08-06       Impact factor: 56.272

6.  Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.

Authors:  T C Fagan; C Sternleib; N Vlachakis; P C Deedwania; J L Mehta
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

7.  What is the value of home blood pressure measurement in patients with mild hypertension?

Authors:  H D Kleinert; G A Harshfield; T G Pickering; R B Devereux; P A Sullivan; R M Marion; W K Mallory; J H Laragh
Journal:  Hypertension       Date:  1984 Jul-Aug       Impact factor: 10.190

Review 8.  Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  K L Goa; E M Sorkin
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

9.  Bisoprolol versus hydrochlorothiazide plus amiloride in essential hypertension, a randomized double-blind study.

Authors:  P Honoré
Journal:  Eur Heart J       Date:  1987-12       Impact factor: 29.983

10.  Personality differences between hypertensive and normotensive individuals: influence of knowledge of hypertension status.

Authors:  M J Irvine; D M Garner; M P Olmsted; A G Logan
Journal:  Psychosom Med       Date:  1989 Sep-Oct       Impact factor: 4.312

View more
  3 in total

1.  CLOCK-BMAL1 regulates circadian oscillation of ventricular arrhythmias in failing hearts through β1 adrenergic receptor.

Authors:  Zihao Zhou; Jiamin Yuan; Didi Zhu; Yanhong Chen; Zhiyong Qian; Yao Wang; Peibin Ge; Quanpeng Wang; Xiaofeng Hou; Jiangang Zou
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 2.  Therapeutic applications of circadian rhythms for the cardiovascular system.

Authors:  Elena V Tsimakouridze; Faisal J Alibhai; Tami A Martino
Journal:  Front Pharmacol       Date:  2015-04-17       Impact factor: 5.810

3.  In Silico comparison between metoprolol succinate and bisoprolol on 24-hour systolic blood pressures.

Authors:  Sven-Olof Jansson; Anders E Malm; Torbjörn Lundström
Journal:  Drugs R D       Date:  2014-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.